NasdaqGS - Delayed Quote USD
Xilio Therapeutics, Inc. (XLO)
0.6783
+0.0124
+(1.86%)
At close: June 5 at 4:00:01 PM EDT
0.6905
+0.01
+(1.80%)
Pre-Market: 8:13:38 AM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
21,102
-18,378
-68,620
-75,723
-80,751
Investing Cash Flow
-58
-36
-486
-1,867
-1,100
Financing Cash Flow
33,074
29,196
-6,550
-69
260,668
End Cash Position
90,861
57,073
46,291
121,947
199,606
Interest Paid Supplemental Data
0
62
573
555
492
Capital Expenditure
-995
-36
-486
-1,867
-1,100
Issuance of Capital Stock
7,344
6,825
0
0
261,245
Issuance of Debt
--
--
--
0
975
Repayment of Debt
-28
-3,382
-6,752
-85
-1,085
Free Cash Flow
21,044
-18,414
-69,106
-77,590
-81,851
12/31/2021 - 10/22/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CDT Conduit Pharmaceuticals Inc.
2.7000
+0.75%
PSTV Plus Therapeutics, Inc.
0.3190
-9.55%
INAB IN8bio, Inc.
0.1201
-1.96%
REVB Revelation Biosciences, Inc.
0.8150
-7.85%
KAPA Kairos Pharma, Ltd.
0.5025
-3.48%
TOVX Theriva Biologics, Inc.
0.4710
+2.84%
ATHA Athira Pharma, Inc.
0.3412
+3.39%
SILO Silo Pharma, Inc.
0.6400
+12.08%
TRVI Trevi Therapeutics, Inc.
6.74
+2.43%
PHIO Phio Pharmaceuticals Corp.
2.4600
+17.14%